FGF-SAP References

Cat #IT-38

Dickey DD, Thomas GS, Dassie JP, Giangrande PH. (2016) Method for Confirming Cytoplasmic Delivery of RNA Aptamers. Methods Mol Biol 1364:209-217. PMID: 26472453 (Targeting Trends 16q1)

Esko JD, Stanley P. (2015) Glycosylation Mutants of Cultured Mammalian Cells. Essentials of GlycobiologyPMID: 28876848

Hernandez, LI, Flenker, KS, Hernandez, FJ, Klingelhutz, AJ, McNamara, JO, 2nd, & Giangrande, PH. (2013). Methods for Evaluating Cell-Specific, Cell-Internalizing Rna Aptamers. Pharmaceuticals (Basel), 6 (3):295-319. PMID: 23894227 (read summary)

Liao D, Lin PH, Yao Q, Chen C (2008) Vascular smooth cell proliferation in perfusion culture of porcine carotid arteries. Biochem Biophys Res Commun 372(4):668-673. (Targeting Trends 08q3)

Beitz JG, Davol P, Clark JW, Kato J, Medina M, Frackelton AR, Jr., Lappi DA, Baird A, Calabresi P (1992) Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. Cancer Res 52:227-230.

David T, Tassin J, Lappi DA, Baird A, Courtois Y (1992) Biphasic effect of the mitotoxin bFGF-saporin on bovine lens epithelial cell growth: effect of cell density and extracellular matrix. J Cell Physiol 153:483-490.

Gonzalez AM, Lappi DA, Buscaglia ML, Carman LS, Gage FH, Baird A (1991) Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor. Ann N Y Acad Sci 638:442-444.

Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA (1991) Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68:106-113.

Beattie GM, Lappi DA, Baird A, Hayek A (1990) Selective elimination of fibroblasts from pancreatic islet monolayers by basic fibroblast growth factor-saporin mitotoxin. Diabetes 39:1002-1005.